A robust expression and purification platform for bsAb modalities

The seminar focuses on key areas of ADD. Starting with antibody discovery platforms to identify and optimize candidate molecules, we use techniques like high-throughput screening and a suite of analytics coupled with AI-ML to identify targets and design and screen candidate molecules. This end-to-end approach has the potential to significantly reduce both the time and cost of drug development while improving the success rate of biologics in the clinic.